TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01204255

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lorazepam
Description: Given topically

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: diphenhydramine hydrochloride
Description: Given topically

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: haloperidol
Description: Given topically

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study: NCT04359355

Intervention type: DEVICE
Intervention: Artificial Intelligence System for Detection of colorectal polyps
Description: In this group, an artificial Intelligence System will be used for computer-aided diagnosis of colorectal polyps. Diagnostic Performance of the artificial intelligence System for detection of polyps will be compared against Operator-based detection in the same group
Study: NCT03925818

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bismuth Subcitrate Potassium
Description: Pylera capsules

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Gastrus
Description: Gastrus 1 tablet
Study: NCT01985789

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study: NCT04951531

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: BPTB double-bundle allograft
Description: The patient underwent surgery of arthroscopic double-bundle anterior cruciate ligament (ACL) reconstruction with bone-patellar tendon-bone (BPTB) allograft．

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: BPTB single-bundle allograft group
Description: The patient underwent surgery of arthroscopic single-bundle anterior cruciate ligament (ACL) reconstruction with bone-patellar tendon-bone (BPTB) allograft．

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: BPTB single-bundle autograft group
Description: The patient underwent surgery of arthroscopic single-bundle anterior cruciate ligament (ACL) reconstruction with bone-patellar tendon-bone (BPTB) autograft．
Study: NCT02450825

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Lung ultrasound examination on Day 1 and Day 2 to 4
Description: A standardized lung ultrasound examination using the GE Vivid ultrasound system will be performed following the tomographic scan on Day 1 and repeated on Day 2 to 4. Correlation of ultrasound-based aeration scores will be done with lung aeration measured by computed tomographic images.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Lung ultrasound examination on Day 1
Description: A standardized lung ultrasound examination using the GE Vivid ultrasound system will be performed following the tomographic scan on Day 1 only. Correlation of ultrasound-based aeration scores will be done with lung aeration measured by computed tomographic images.

Intervention type: DEVICE
Group type: OTHER
Intervention: GE Vivid Ultrasound system
Description: The GE Vivid ultrasound system will be used for all lung ultrasound examinations performed in this study.

Intervention type: DEVICE
Group type: OTHER
Intervention: GE Vivid Ultrasound system
Description: The GE Vivid ultrasound system will be used for all lung ultrasound examinations performed in this study.
Study: NCT01738243

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid Gel injection
Description: The conjunctiva is anesthetized with Proparacaine Hydrochloride Ophthalmic Solution, 0.5%. The upper eyelid is everted and the conjunctiva just superior to the upper tarsal edge is exposed. Using a 30-gauge needle, a single bolus of Hyaluronic Acid Gel is placed centrally in the subconjunctival levator-Muller plane. Small volumes (0.1 to 0.2 ml) of Hyaluronic Acid Gel are injected with the end point being adequate lowering with improved symmetry.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid Gel injection
Description: The conjunctiva is anesthetized with Proparacaine Hydrochloride Ophthalmic Solution, 0.5%. The upper eyelid is everted and the conjunctiva just superior to the upper tarsal edge is exposed. Using a 30-gauge needle, a single bolus of Hyaluronic Acid Gel is placed centrally in the subconjunctival levator-Muller plane. Small volumes (0.1 to 0.2 ml) of Hyaluronic Acid Gel are injected with the end point being adequate lowering with improved symmetry.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline injection
Description: The conjunctiva is anesthetized with Proparacaine Hydrochloride Ophthalmic Solution, 0.5%. The upper eyelid is everted and the conjunctiva just superior to the upper tarsal edge is exposed. Using a 30-gauge needle, a single bolus of saline is placed centrally in the subconjunctival levator-Muller plane. Small volumes (0.1 to 0.2 ml) of saline are injected with the end point being adequate lowering with improved symmetry.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline injection
Description: The conjunctiva is anesthetized with Proparacaine Hydrochloride Ophthalmic Solution, 0.5%. The upper eyelid is everted and the conjunctiva just superior to the upper tarsal edge is exposed. Using a 30-gauge needle, a single bolus of saline is placed centrally in the subconjunctival levator-Muller plane. Small volumes (0.1 to 0.2 ml) of saline are injected with the end point being adequate lowering with improved symmetry.
Study: NCT00987350

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LectraJet
Description: LectraJet is a new jet injector studied for the first time in humans. It is in the category known as disposable-syringe jet injectors that have the advantage of eliminating the risk of disease transmission between subjects. A new syringe and nozzle is used for each patient so that no splash back of blood can occur onto the jet apparatus itself.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TIV by jet injection
Description: Administration of seasonal trivalent influenza vaccine (TIV) by jet injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Seasonal Trivalent Influenza Vaccine
Description: Licensed trivalent influenza vaccine provided by either jet injection or traditional needle and syringe.
Study: NCT02819115

Intervention type: BIOLOGICAL
Intervention: Butantan Fragmented Inactivated Trivalent Influenza Vaccine
Description: Butantan Fragmented Inactivated Trivalent Influenza Vaccine

Intervention type: BIOLOGICAL
Intervention: Butantan Fragmented Inactivated Trivalent Influenza Vaccine
Description: Butantan Fragmented Inactivated Trivalent Influenza Vaccine
Study: NCT01670214

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pulsed electromagnetic field
Description: parameters of the pulsed electromagnetic field are frequency:10 Hz, intensity 4-5 mT, 6 sessions( 2 week) for placebo and phase 1 treatment ( 3 sessions in week) and added 6 sessions for phase 2 treatment. the solenoid diameter of instrument is 70 cm is placed around the head.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: pulsed electromagnetic field
Description: parameters of the pulsed electromagnetic field are frequency:10 Hz, intensity 4-5 mT, 6 sessions( 2 week) for placebo and phase 1 treatment ( 3 sessions in week) and added 6 sessions for phase 2 treatment. the solenoid diameter of instrument is 70 cm is placed around the head.
Study: NCT03134508

Intervention type: OTHER
Intervention: treated by antiTNFα
Description: pregnant IBD women treated by antiTNFα

Intervention type: OTHER
Intervention: not treated by antiTNFα
Description: pregnant IBD women not treated by antiTNFα
Study: NCT04748406

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Extracorporeal Shock Wave Therapy(ESWT)
Description: Group 2 (n = 35) will be applied 1 session per week for 3 weeks, 3 sessions of ESWT (1.8 bar, 10.0 Hz, 2000 beats) + cold application + home exercise program will be applied.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Peloid therapy
Description: Group 1 (n = 35) will be given 15 sessions of peloid therapy + cold application + home exercise program for 3 weeks, 5 days a week

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home Workout Program
Description: Patients will be given a home exercise program consisting of eccentric strengthening exercises and stretching exercises, which are planned to increase resistance every week. The patients will be taught strengthening exercises for forearm pronation-supination with wrist extensors and a home exercise program will be started 3 sets of 10 repetitions per day.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home Workout Program
Description: Patients will be given a home exercise program consisting of eccentric strengthening exercises and stretching exercises, which are planned to increase resistance every week. The patients will be taught strengthening exercises for forearm pronation-supination with wrist extensors and a home exercise program will be started 3 sets of 10 repetitions per day.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cold application
Description: At the beginning of each treatment, gel ice packs are wrapped with a moist towel and placed around the elbow joint for 15 minutes. will be applied.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cold application
Description: At the beginning of each treatment, gel ice packs are wrapped with a moist towel and placed around the elbow joint for 15 minutes. will be applied.
Study: NCT02417909

Intervention type: OTHER
Intervention: questionnaires about quality of life
Description: all teenagers included in the trial and their parents must complete the questionnaires given of them the day of enrollment.

Intervention type: OTHER
Intervention: questionnaires about quality of life
Description: all teenagers included in the trial and their parents must complete the questionnaires given of them the day of enrollment.
Study: NCT02430428

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Carl Zeiss Meditec VisuMax Femtosecond Laser
Description: VisuMax femtosecond laser sphere-only or spherocylindrical treatment
Study: NCT01699620

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: BAHA implant insertion
Description: The intervention is insertion of the Cochlear Bi300 to be used for bone anchored hearing aid.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: BAHA implant insertion
Description: The intervention is insertion of the Cochlear Bi300 to be used for bone anchored hearing aid.
Study: NCT04012944

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cordella™ Pulmonary Artery Sensor System
Description: The Cordella PA Sensor System comprises seven subsystems that operate together to take daily Pulmonary Artery Pressure (PAP) readings at a patient's home and transmit the results to a care provider for evaluation.~1. Cordella Sensor~2. Cordella Delivery System~3. myCordella Patient Reader~4. Reader Dock~5. Cordella Calibration Equipment (CalEQ)~6. myCordella Hub~7. Cordella Data Analysis Platform (CDAP).
Study: NCT01094730

Intervention type: DEVICE
Group type: OTHER
Intervention: galyfilcon A prototype lens
Description: Experimental silicone hydrogel contact lens

Intervention type: DEVICE
Group type: OTHER
Intervention: galyfilcon A prototype lens
Description: Experimental silicone hydrogel contact lens

Intervention type: DEVICE
Group type: OTHER
Intervention: marketed galyfilcon A lens
Description: Marketed silicone hydrogel contact lens.

Intervention type: DEVICE
Group type: OTHER
Intervention: marketed galyfilcon A lens
Description: Marketed silicone hydrogel contact lens.
Study: NCT03196310

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platelet Concentrate
Description: Platelet Rich plasma

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid injection
Description: Kenalog
Study: NCT00674830

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: professionally administered cognitive-behavioral therapy
Description: professionally administered CBT-I consisting of six weekly sessions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: self-administered form of cognitive-behavioral therapy
Description: self-administered CBT-I consisting of six short booklets and videotapes

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: usual care
Study: NCT02492997

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Venus Versa
Description: The Venus Versa system is a console that supports an applicators that simultaneously emits radio frequency (RF) and a Pulsed Magnetic Field (PEMF). This combination of energy can raise the temperature of treatment area quickly and homogeneously. The Pulsed Magnetic Field is induced by short pulses of electrical current through coil in the applicator. The magnetic field penetrates into the skin and results in Foucault (Eddy) electrical currents around the cell membranes of the treated tissues. Foucault currents change the electrical potential of charged receptors on the bi-lipid cell membrane layer of dermal cells, which results in the stimulation of molecular and cellular activities and reactions.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Venus Versa
Description: The Venus Versa system is a console that supports an applicators that simultaneously emits radio frequency (RF) and a Pulsed Magnetic Field (PEMF). This combination of energy can raise the temperature of treatment area quickly and homogeneously. The Pulsed Magnetic Field is induced by short pulses of electrical current through coil in the applicator. The magnetic field penetrates into the skin and results in Foucault (Eddy) electrical currents around the cell membranes of the treated tissues. Foucault currents change the electrical potential of charged receptors on the bi-lipid cell membrane layer of dermal cells, which results in the stimulation of molecular and cellular activities and reactions.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Glycerine gel
Description: Gel used to protect the skin from the RF energy and to assist with energy distribution

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glycerine gel
Description: Gel used to protect the skin from the RF energy and to assist with energy distribution
Study: NCT04362449

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Shortened hydration time and dispensary of Akynzeo
Description: Hydration is reduced to 1 hour and 40 minutes and Akynzeo is administered as an oral drug instead of Ondansetron being given as an IV before chemotherapy.

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Hydration remains at around 6 hours and 30 minutes due to no oral fluids being consumed prior to treatment and normal saline being administered for 90 minutes before cisplatin and then for 2 hours after cisplatin and before gemcitabine administration
Study: NCT03783052

Intervention type: DEVICE
Group type: OTHER
Intervention: SmartPill in fasted state
Description: SmartPill administration in fasted state

Intervention type: DEVICE
Group type: OTHER
Intervention: SmartPill in fasted state
Description: SmartPill administration in fasted state

Intervention type: DEVICE
Group type: OTHER
Intervention: SmartPill in fasted state
Description: SmartPill administration in fasted state

Intervention type: DEVICE
Group type: OTHER
Intervention: SmartPill in fasted state
Description: SmartPill administration in fasted state

Intervention type: DEVICE
Group type: OTHER
Intervention: SmartPill in fasted state
Description: SmartPill administration in fasted state

Intervention type: DEVICE
Group type: OTHER
Intervention: SmartPill in fed state
Description: SmartPill administration in fed state

Intervention type: DEVICE
Group type: OTHER
Intervention: SmartPill in fed state
Description: SmartPill administration in fed state

Intervention type: OTHER
Group type: OTHER
Intervention: Aspiration
Description: Aspiration of gastrointestinal samples in fasted and fed state

Intervention type: OTHER
Group type: OTHER
Intervention: Aspiration
Description: Aspiration of gastrointestinal samples in fasted and fed state

Intervention type: OTHER
Group type: OTHER
Intervention: Aspiration
Description: Aspiration of gastrointestinal samples in fasted and fed state
Study: NCT03438539

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Normative Feedback
Description: Subjects assigned to normative feedback will be directed to a statement standardized based on subjects' reported average number of standard drinks per week, age, and gender.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Normative Feedback
Description: Subjects assigned to normative feedback will be directed to a statement standardized based on subjects' reported average number of standard drinks per week, age, and gender.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inhibitory Control Training
Description: The inhibitory control training task is a modified version of the Cued Go/No-Go tasks (Weafer and Fillmore, 2012; Miller et al. 1991) and is based on a task currently used in our laboratory targeting cocaine inhibitory control.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inhibitory Control Training
Description: The inhibitory control training task is a modified version of the Cued Go/No-Go tasks (Weafer and Fillmore, 2012; Miller et al. 1991) and is based on a task currently used in our laboratory targeting cocaine inhibitory control.
Study: NCT03783052

Intervention type: OTHER
Group type: OTHER
Intervention: Gastric emptying scintigraphy
Description: Gastric emptying scintigraphy in fed state

Intervention type: OTHER
Group type: OTHER
Intervention: Gastric emptying scintigraphy
Description: Gastric emptying scintigraphy in fed state
Study: NCT01880502

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belviq 10mg
Description: Belviq 10mg single dose administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belviq 20mg
Description: Belviq 20mg single dose administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo single dose administration
Study: NCT01577368

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Piperacillin-Tazobactam continuous infusion
Description: Piperacillin-Tazobactam 2gr (Loading dose DAY 1) plus Piperacillin-Tazobactam continuous infusion 8gr every 24 hours (DAY 1-14)
Study: NCT03196310

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: Control Group - Placebo
Study: NCT03438539

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Working Memory Training
Description: A battery of working memory tasks will be used during the intervention period. These tasks were selected from previous research evaluating working memory training in substance use disorder (Bickel et al., 2011b; Houben et al., 2011b). Tasks will include visuospatial working memory task, digit span task, letter span task, and the n-back task.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Working Memory Training
Description: A battery of working memory tasks will be used during the intervention period. These tasks were selected from previous research evaluating working memory training in substance use disorder (Bickel et al., 2011b; Houben et al., 2011b). Tasks will include visuospatial working memory task, digit span task, letter span task, and the n-back task.
Study: NCT01025674

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Action program
Description: Components of the Positive Action program (6 units) use research-supported educational strategies/methods that include active learning, positive classroom management, teacher training, detailed curriculum with almost daily lessons, school-wide climate-change program, and family program of parent support/involvement.
Study: NCT03131622

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Therapeutics
Study: NCT01577368

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Piperacillin-Tazobactam intermittent infusion
Description: Piperacillin-Tazobactam intermittent infusion 4gr every 8 hours (DAY 1-14)
Study: NCT00987350

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Seasonal Trivalent Influenza Vaccine
Description: Licensed trivalent influenza vaccine provided by either jet injection or traditional needle and syringe.
Study: NCT00825682

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reflexology treatment.
Description: Reflexology treatments (45 min. each) will be initiated at the beginning of radiation therapy, once a week, for 10 weeks.The treatment includes manual pressure on specific points of foot soles and massage of the calf area, adapted individually to each patient.
Study: NCT03680560

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ACTR T Cell Product
Description: Autologous Antibody-Coupled T Cell Receptor (ACTR) T Cell Product (ACTR707 or ACTR087)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: monoclonal antibody targeting HER2
Study: NCT00115739

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imatinib
Description: Imatinib 400 mg capsules were administered twice daily with food for 4 week cycles.
Study: NCT01991860

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APD421- Amisulpride for IV injection
Description: APD421 ( Amisulpride) at 5mg given by single intravenous (IV) administration, by slow push over one minute, at induction of anaesthesia

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo given by single intravenous (IV) administration, by slow push over one minute, at induction of anaesthesia
Study: NCT03900442

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTX-100
Description: Doses of 500 to 2000 mg/m2 will be administered.
Study: NCT02930330

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: INT
Description: * 5 min warm-up (40% Pmax\*)~* 30 min high intensity interval training (1 min 100% Pmax, 1 min 20% Pmax, in alternating sequence)~* 10 min cool-down (30% Pmax)~Pmax\*: Maximal power output (Watt) achieved at the end of an incremental exercise test.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CONT
Description: * 5 min warm-up (40% Pmax\*)~* 30 min moderate intensity continuous training (60% Pmax)~* 10 min cool-down (30% Pmax)~Pmax\*: Maximal power output (Watt) achieved at the end of an incremental exercise test.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CONT
Description: * 5 min warm-up (40% Pmax\*)~* 30 min moderate intensity continuous training (60% Pmax)~* 10 min cool-down (30% Pmax)~Pmax\*: Maximal power output (Watt) achieved at the end of an incremental exercise test.
Study: NCT04035499

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: GO-EXCAP Mobile App
Description: A mobile app delivery platform and the EXCAP©® exercise program